2359 - Aripiprazole

Material & Volume
  • Serum, 1ml
Clinical Information

Aripiprazol is an active ingredient of the group of atypical neuroleptic agents and is administered for treating schizophrenia and manic episodes of bipolar disorders . The therapeutic effects are based upon an antagonism at the serotonin-5HT2a-receptors and a partial agonism at the dopamin-D2-receptors and the serotonin-5HT1a-receptors. This means, that aripiprazol can regulate the dopamine concentration from two aspects, and also has an antagonistic effect on the serotonin receptors as other atypical neuroleptics. Thus the effective ingredient is counted as part of the third generation neuroleptics. Frequent side effects are headache, persistent nausea, sleeplessness and constipation.

Type of drug: Antipsychotic
Metabolism: CYP2D6, CYP3A4, P-gp(ABCB1)
Half life t½: 60-80h, Dehydroaripiprazole: 94h
Steady State: 2weeks
TDM: recommended
Additional Informations: Dehydro aripiprazole is also an active metabolite

More information
Related analyses
Description Material
Aripiprazole Serum
Dehydroaripiprazole Serum
Total Calculated
Product names
Analyses groups
  • Abilify®
Position / Price
Position: 1579.00
Price: CHF 126.00
+ Processing fee:
(per order and per day)
CHF 21.60
Executing laboratory
labor team w ag
Blumeneggstrasse 55
9403 Goldach
Execution time
1 day
During opening-hours:
Outside opening-hours: